Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. - sprookjes - yvandenbroek - TriplyDB

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

http://www.wikidata.org/entity/Q43601180

about

Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols Radiofrequency ablation of liver tumors Treatment algorithms for managing hepatocellular carcinoma A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Radiofrequency ablation of hepatocellular carcinoma: a literature review Radiofrequency ablation of hepatocellular carcinoma: Current status Complications after interventional sonography of focal liver lesions: a 22-year single-center experience.Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments.Review article: percutaneous treatment of hepatocellular carcinoma.Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma.Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up Thermal ablation of hepatocellular carcinoma.The imprint of radiofrequency in the management of hepatocellular carcinoma No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers Transcatheter infusion of epirubicin in water-in-oil-in-water emulsion via a cystic artery for the treatment of hepatocellular carcinoma.Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma.Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation Non-surgical treatment of hepatocellular carcinoma.Evaluation of ghost cell survival in the area of radiofrequency ablation.Prognostic prediction and treatment strategy in hepatocellular carcinoma.Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm.Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings.Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy.Treatment of non-resectable hepatocellular carcinoma.Evidence-based medicine in the treatment of hepatocellular carcinoma.Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography Review article: liver transplantation for HCC. Treatment options on the waiting list.Role of FNAC in Hepatic lesions: Risk of track metastases.Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience

P2860

Q26783881-7AB74D34-2987-45BA-A253-071F0E2BA7C3 Q26853330-5883252B-D0E7-4493-9C0D-6585E0DA32C4 Q27027923-E81D9E51-4BC6-4A73-8CC9-1989F136DA9F Q28067517-99A6B18B-6CA7-4E45-AEC3-91F884F48874 Q28076314-B72E94DF-D858-4AB8-A0B2-D1A4F301E3DD Q28344370-4B1188B7-0BB3-41C5-8282-CABB78F1E2DC Q30468280-F139B569-3DEC-4104-B928-6BD9E3D4A6CF Q30473747-D4EDD32C-2E21-41FA-BFAC-FBCD800E820A Q30478030-48F13DC3-C236-48D8-9ED3-8330619A90BE Q30884625-44CAB364-1A12-4F41-8146-B1B6425A5EC0 Q30937758-CE6BDCE3-EA03-4D57-BF6D-16AE194EB000 Q30942931-C7929704-1D53-44C1-BDB0-6AF6CBE913B3 Q31117645-A63D7121-AD4F-4F97-9432-D8A34560339D Q33208819-B3E37D46-A99D-46E0-8BDA-6FA830D124EE Q33323261-9D78D245-4E19-4589-887D-BA2C8D9CFD6E Q33323289-5CA80125-C436-4EE3-8F85-7952434952B0 Q33605872-6A4AF582-5781-42C0-998A-0AF89301AA81 Q33698997-2E948A2E-9948-4F08-B1B4-5533904F6E0E Q33868149-450FD885-7054-45E8-A7C4-1EB71D9DAE21 Q33935631-44137918-14C6-49D1-AAC8-B3CD4AF94D6D Q34098980-7FA31273-EC3B-4A26-A462-9AA02FA74FBE Q34224741-D67D543C-0E17-41AF-AB4F-4FFE3A752E19 Q34482350-5A37B280-445A-4127-A4EC-B8A00B0658E0 Q34539241-F28F31BD-14D9-4634-A222-D82E062C52ED Q34541720-FD80D3D0-3933-4968-97B3-96D89D0091AB Q34547469-F0686E06-FB88-499B-97CC-F9AE215586CE Q34551964-39F735E1-0A49-42AE-8FA8-A721312C88BF Q34552875-DABF4673-5A54-4B07-952F-147F9B22CAB2 Q34595503-29D1FF2F-7F9F-4A58-92E8-0AD79A5AC4F2 Q34606217-C7B26517-A356-4B21-98A2-8B9E02AD342B Q34959633-E1145682-FE6A-42C0-A588-DE83C49230F5 Q35010404-9E88EA54-A771-4B1E-93E5-8CA457EB223E Q35020886-9D279A72-1951-4065-ACC4-9E76983566F6 Q35020890-069B0E4E-4EBA-4B8B-84AE-4817C2A9EE21 Q35045761-6E1ECC4E-396B-4D15-9F1C-EBB5073D484F Q35093299-21B99EDD-1277-4449-976D-CCFEFB6CDF9B Q35145087-9018FED7-C76C-480B-89ED-CECF550EE676 Q35245527-DCE360DA-C6F2-4D56-A9EE-43EBC3D3C766 Q35435327-3D153928-57D9-4638-BAC0-BB87DD500966 Q35469004-7062BED9-C5D0-4010-867D-2829D6855C01

P2860

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

http://www.wikidata.org/entity/Q43601180

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Increased risk of tumor seedin ...... ngle hepatocellular carcinoma.

@en

Increased risk of tumor seedin ...... ngle hepatocellular carcinoma.

@nl

type

label

Increased risk of tumor seedin ...... ngle hepatocellular carcinoma.

@en

Increased risk of tumor seedin ...... ngle hepatocellular carcinoma.

@nl

prefLabel

Increased risk of tumor seedin ...... ngle hepatocellular carcinoma.

@en

Increased risk of tumor seedin ...... ngle hepatocellular carcinoma.

@nl

P1433

Q43601180-D60146CB-1869-4F20-A54C-AA96D25DE630

P1476

Q43601180-CD962440-4D15-46FE-87E5-3FC07341010A

P2093

Q43601180-057314D2-DA41-4F20-B02D-C03DF35BF16A

Q43601180-64EFDB74-1DE2-4DE5-A83E-73B0467515CB

Q43601180-84B74613-E04B-473A-93D5-00615D243F86

Q43601180-9227BAED-4EF1-4873-BE17-D2B8E6A5BF94

Q43601180-9AD6AF01-E185-495A-AC1C-D781BFB7C6E5

Q43601180-A8FB2157-BAA4-4AC1-8A41-C76BC1981F6E

Q43601180-B2A1DA0E-1B4A-40C3-8F73-7DFFCF3DD67B

Q43601180-BBB527E4-08EB-4A32-8F5F-70279E5853BD

Q43601180-BEEE61D4-2061-4FBA-A47C-9CAE7E5986DB

Q43601180-EF08EACF-0769-4579-A1AB-EE1196A3477D

P304

Q43601180-76DC5880-C342-4946-8281-692C70C00FEF

P31

Q43601180-BF6E4C69-EF51-4A9B-96D6-9761CAE6DE75

P356

Q43601180-6CF5B5C2-42D3-4721-A3CA-02E8FA63B512

P407

Q43601180-B27708A2-5F4B-42F3-9DB9-EDA5E6559667

P433

Q43601180-3C67A306-96A7-4262-9440-E3CB0DA20B60

P478

Q43601180-61DF4910-4F2D-47E9-900B-678E69DA3C41

P50

Q43601180-1F29D563-09DA-4DBD-99CA-3745EE8F6145

Q43601180-68E4D77D-95D6-4F4D-844C-57EE0012F0B5

Q43601180-98CA475B-6C7D-420F-A472-BCC46615F72C

P577

Q43601180-E1EADF1D-46AA-4EDD-AE97-8EA10A82FD24

P5875

Q43601180-FC01AB6B-96CC-44BA-B0F9-360762F99C43

P698

Q43601180-24F79176-2C89-4789-AC63-EB57A951D9CD

P356

JHEP.2001.24233

P1433

P1476

Increased risk of tumor seedin ...... ingle hepatocellular carcinoma

@en

P2093

Barcelona Clínic Liver Cancer (BCLC) Group

http://www.w3.org/2001/XMLSchema#string

C Brú

http://www.w3.org/2001/XMLSchema#string

J M Salmeron

http://www.w3.org/2001/XMLSchema#string

J Rodés

http://www.w3.org/2001/XMLSchema#string

L Bianchi

http://www.w3.org/2001/XMLSchema#string

L Boix

http://www.w3.org/2001/XMLSchema#string

M Pagès

http://www.w3.org/2001/XMLSchema#string

M Sala

http://www.w3.org/2001/XMLSchema#string

M Solé

http://www.w3.org/2001/XMLSchema#string

R Vilana

http://www.w3.org/2001/XMLSchema#string

P304

1124-1129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JHEP.2001.24233

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Josep M. Llovet

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11994538

http://www.w3.org/2001/XMLSchema#string

P698

11343240

http://www.w3.org/2001/XMLSchema#string